OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of Smad signaling cascades in cardiac fibrosis
Anis Hanna, Claudio Humeres, Nikolaos G. Frangogiannis
Cellular Signalling (2020) Vol. 77, pp. 109826-109826
Open Access | Times Cited: 94
Anis Hanna, Claudio Humeres, Nikolaos G. Frangogiannis
Cellular Signalling (2020) Vol. 77, pp. 109826-109826
Open Access | Times Cited: 94
Showing 1-25 of 94 citing articles:
Chromatin remodelling drives immune cell–fibroblast communication in heart failure
Michael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 434-443
Closed Access | Times Cited: 18
Michael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 434-443
Closed Access | Times Cited: 18
Fibrosis of the diabetic heart: Clinical significance, molecular mechanisms, and therapeutic opportunities
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 86
Izabela Tuleta, Nikolaos G. Frangogiannis
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113904-113904
Open Access | Times Cited: 86
Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling
Yuze Zhang, Xiaoyan Lin, Yong Chu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Yuze Zhang, Xiaoyan Lin, Yong Chu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Lung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Elena Ortiz‐Zapater, Jaime Signes‐Costa, Paula Montero, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1423-1423
Open Access | Times Cited: 54
Elena Ortiz‐Zapater, Jaime Signes‐Costa, Paula Montero, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1423-1423
Open Access | Times Cited: 54
Reduction of Cardiac Fibrosis by Interference With YAP-Dependent Transactivation
Gloria Garoffolo, Manuel Casaburo, Francesco Amadeo, et al.
Circulation Research (2022) Vol. 131, Iss. 3, pp. 239-257
Open Access | Times Cited: 53
Gloria Garoffolo, Manuel Casaburo, Francesco Amadeo, et al.
Circulation Research (2022) Vol. 131, Iss. 3, pp. 239-257
Open Access | Times Cited: 53
Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 48
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 48
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Yanan Cheng, Yan Wang, Ruili Yin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 27
Deciphering the fibrotic process: mechanism of chronic radiation skin injury fibrosis
Yiren Wang, Shouying Chen, Shuilan Bao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Yiren Wang, Shouying Chen, Shuilan Bao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
Cardiac fibrosis: Pathobiology and therapeutic targets
Michael P. Czubryt, Taben M. Hale
Cellular Signalling (2021) Vol. 85, pp. 110066-110066
Open Access | Times Cited: 43
Michael P. Czubryt, Taben M. Hale
Cellular Signalling (2021) Vol. 85, pp. 110066-110066
Open Access | Times Cited: 43
Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
Kamila Raziyeva, Yevgeniy Kim, Zharylkasyn Zharkinbekov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2178-2178
Open Access | Times Cited: 33
Kamila Raziyeva, Yevgeniy Kim, Zharylkasyn Zharkinbekov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2178-2178
Open Access | Times Cited: 33
A two-way street – cellular metabolism and myofibroblast contraction
Anne Noom, Birgit Sawitzki, Petra Knaus, et al.
npj Regenerative Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Anne Noom, Birgit Sawitzki, Petra Knaus, et al.
npj Regenerative Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Mechanosensor YAP cooperates with TGF-β1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis
Sara Ragazzini, Franca Scocozza, Giacomo Bernava, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 300-312
Closed Access | Times Cited: 22
Sara Ragazzini, Franca Scocozza, Giacomo Bernava, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 300-312
Closed Access | Times Cited: 22
Protein–protein interaction network-based integration of GWAS and functional data for blood pressure regulation analysis
Evridiki-Pandora Tsare, Maria I. Klapa, Nicholas Κ. Moschonas
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Evridiki-Pandora Tsare, Maria I. Klapa, Nicholas Κ. Moschonas
Human Genomics (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Hitting the Target! Challenges and Opportunities for TGF-β Inhibition for the Treatment of Cardiac fibrosis
Maria Vistnes
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 267-267
Open Access | Times Cited: 5
Maria Vistnes
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 267-267
Open Access | Times Cited: 5
Inhibitory effect of microRNA-21 on pathways and mechanisms involved in cardiac fibrosis development
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, et al.
Therapeutic Advances in Cardiovascular Disease (2024) Vol. 18
Open Access | Times Cited: 4
Amirreza Khalaji, Saba Mehrtabar, Armin Jabraeilipour, et al.
Therapeutic Advances in Cardiovascular Disease (2024) Vol. 18
Open Access | Times Cited: 4
Fibroblast-specific TGF-β signaling mediates cardiac dysfunction, fibrosis, and hypertrophy in obese diabetic mice
Izabela Tuleta, Anis Hanna, Claudio Humeres, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 4
Izabela Tuleta, Anis Hanna, Claudio Humeres, et al.
Cardiovascular Research (2024)
Closed Access | Times Cited: 4
Sympathetic nociceptive afferent signaling drives the chronic structural and functional autonomic remodeling after myocardial infarction
Valerie Van Weperen, Jonathan D. Hoang, Neil Jani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Valerie Van Weperen, Jonathan D. Hoang, Neil Jani, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Sympathetic nociceptive afferent signaling drives the chronic structural and functional autonomic remodeling after myocardial infarction
Marmar Vaseghi, Valerie van Weperen, Jonathan D. Hoang, et al.
Research Square (Research Square) (2025)
Open Access
Marmar Vaseghi, Valerie van Weperen, Jonathan D. Hoang, et al.
Research Square (Research Square) (2025)
Open Access
Transcription Factors Involved in the Development and Prognosis of Cardiac Remodeling
Jia‐Hui Hong, Haigang Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Jia‐Hui Hong, Haigang Zhang
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Smad-dependent pathways in the infarcted and failing heart
Claudio Humeres, Harikrishnan Venugopal, Nikolaos G. Frangogiannis
Current Opinion in Pharmacology (2022) Vol. 64, pp. 102207-102207
Open Access | Times Cited: 19
Claudio Humeres, Harikrishnan Venugopal, Nikolaos G. Frangogiannis
Current Opinion in Pharmacology (2022) Vol. 64, pp. 102207-102207
Open Access | Times Cited: 19
Novel Cardiokine GDF3 Predicts Adverse Fibrotic Remodeling After Myocardial Infarction
Nihar Masurkar, Marion Bouvet, Damien Logeart, et al.
Circulation (2022) Vol. 147, Iss. 6, pp. 498-511
Open Access | Times Cited: 19
Nihar Masurkar, Marion Bouvet, Damien Logeart, et al.
Circulation (2022) Vol. 147, Iss. 6, pp. 498-511
Open Access | Times Cited: 19
Chromatin Remodeling Drives Immune-Fibroblast Crosstalk in Heart Failure Pathogenesis
Michael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
Michael Alexanian, Arun Padmanabhan, Tomohiro Nishino, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
Pathological insights into activin A: Molecular underpinnings and therapeutic prospects in various diseases
Sejal Kundra, Rupinder Kaur, Chirag Pasricha, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112709-112709
Closed Access | Times Cited: 4
Sejal Kundra, Rupinder Kaur, Chirag Pasricha, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112709-112709
Closed Access | Times Cited: 4
Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs
Mengnan Liu, Xingru Long, Jie Xu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106515-106515
Closed Access | Times Cited: 17
Mengnan Liu, Xingru Long, Jie Xu, et al.
Pharmacological Research (2022) Vol. 185, pp. 106515-106515
Closed Access | Times Cited: 17
circRNA-miRNA-mRNA Deregulated Network in Ischemic Heart Failure Patients
Alisia Madé, Alessia Bibi, José Manuel García-Manteiga, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2578-2578
Open Access | Times Cited: 10
Alisia Madé, Alessia Bibi, José Manuel García-Manteiga, et al.
Cells (2023) Vol. 12, Iss. 21, pp. 2578-2578
Open Access | Times Cited: 10
